Table 3

Type of treatment for glaucoma in DIN-LINK by year for men and women, 1994 to 2003

		1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
*Percentage of total registered.
†Percentage of number treated in year.
Men
Number of registered age ⩾40 years*	No	174 130	189 512	208 551	216 253	231 085	244 603	246 219	249 660	253 600	246 024
Number treated in year	No	2509	2769	3149	3347	3717	4036	4218	4375	4542	4568
	%*	1.44	1.46	1.51	1.55	1.61	1.65	1.71	1.75	1.79	1.86
Type of treatment
β blockers only	No	2241	2466	2763	2879	3089	3246	3134	2929	2649	2,322
	%†	89	89	88	86	83	80	74	67	58	51
Prostaglandins only	No	0	0	0	101	424	901	1366	1889	2347	2697
	%†	0	0	0	3	11	22	32	43	52	59
Cholinergic agents (parasympathomimetics)	No	674	710	741	657	577	492	402	292	258	209
Cholinergic agents (parasympathomimetics)	%†	27	26	24	20	16	12	10	7	6	5
Sympathomimetics (α agonists)	No	458	475	442	367	526	598	556	510	471	419
Sympathomimetics (α agonists)	%†	18	17	14	11	14	15	13	12	10	9
Carbonic anhydrase inhibitors	No	92	129	484	766	933	948	817	770	692	688
	%†	4	5	15	23	25	23	19	18	15	15
Carbonic anhydrase inhibitors and β blockers	No	0	0	0	0	0	106	241	362	442	482
Carbonic anhydrase inhibitors and β blockers	%†	0	0	0	0	0	3	6	8	10	11
Prostaglandins and β blockers	No	0	0	0	0	0	0	0	0	118	237
Prostaglandins and β blockers	%†	0	0	0	0	0	0	0	0	3	5
Women
Number of registered age ⩾40 years	No	198 457	214 511	234 899	241 846	257 155	270 981	271 856	274 176	277 440	267 794
Number treated in year	No	2898	3162	590	3789	4,139	4541	4684	4893	5092	5109
	%*	1.46	1.47	1.53	1.57	1.61	1.68	1.72	1.78	1.84	1.91
Type of treatment
β blockers	No	2530	2805	3127	3264	3458	3567	3384	3171	2904	2531
	%†	87	89	87	86	84	79	72	65	57	50
Prostaglandins	No	0	0	0	97	469	1082	1615	2142	2667	3044
	%†	0	0	0	3	11	24	34	44	52	60
Cholinergic agents (parasympathomimetics)	No	792	820	873	795	657	577	458	375	320	244
Cholinergic agents (parasympathomimetics)	%†	27	26	24	21	16	13	10	8	6	5
Sympathomimetics (α agonists)	No	463	466	437	393	537	607	550	499	426	380
Sympathomimetics (α agonists)	%†	16	15	12	10	13	13	12	10	8	7
Carbonic anhydrase inhibitors	No	127	147	536	798	945	971	816	749	721	714
	%†	4	5	15	21	23	21	17	15	14	14
Carbonic anhydrase inhibitors and β blockers	No	0	0	0	0	0	126	275	391	456	478
Carbonic anhydrase inhibitors and β blockers	%†	0	0	0	0	0	3	6	8	9	9
Prostaglandins and β blockers	No	0	0	0	0	0	0	0	0	114	249
Prostaglandins and β blockers	%†	0	0	0	0	0	0	0	0	2	5